Background and aims
Metabolic dysfunction-associated steatotic liver disease (MASLD) represents an escalating healthcare burden across the Middle East and North Africa (MENA) region; however, system-level preparedness remains…
Assessing health system preparedness for MASLD in the Middle East and North Africa
